Skip to content

The comparative Study of Photothermal activation of Platelet Rich Plama and Non-Activated Platelet rich plasma for the Treatment of Androgenic Alopecia

Comparative study between photo-bioactivated PRP and PRP in AGA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260701009
Enrollment
28
Registered
2026-07-01
Start date
2025-07-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate AGA Norwood-Hamilton grade I-IV Ludwig grade I-II Hair loss Baldness Female pattern hair loss Male pattern hair loss Vertex

Interventions

5ml of PRP will be activated with Red-light 620 nm, combined with 4 degrees Celsius for 15 mins (total joule 60J),Non-activated PRP
Experimental Biological/Vaccine,Active Comparator Biological/Vaccine
Photo thermal bio-activated PRP,non-activated PRP

Sponsors

Thammasat University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male with grade III-IV AGA (Norwood-Hamilton scale) 2. FPHL: Female with grade I-II AGA (Ludwig scale) 3. Patient age: Age between 20 and 60 years old

Exclusion criteria

Exclusion criteria: 1 Patient taking other treatment for the disease prior to the study periods; 2. Medical topical therapies within 3 months 3. On Minoxidil 4. Medical systemic therapies 5. Finasteride within 3 months 6. Dutasteride within 6 months 7. Antiplatelet, Anticoagulant consumption 8. Non-medication: shampoo, stimulating hair growth treatment, and other hair supplements within 3 months 9. Other alternative treatment for hair growth within 1 month 10. Patient with diabetes mellitus, nutritional deficiency, CKD, coronary heart disease, thyroid disease, iron deficiency, liver disease, Infectious, hematologic, or rheumatoid disease 11. Autoimmune disease, immunocompromised conditions 12. HIV infection and cancer. 13. Pregnant and lactating women. 14. Unreliable and poorly compliant patient. 15. Patient with previous hair restoration surgery.

Design outcomes

Primary

MeasureTime frame
hair density before PRP session and 1 month after PRP session for 4 times, and at 1,3,6 months after last PRP hair count

Secondary

MeasureTime frame
hair diameter before PRP session and 1 month after PRP session for 4 times, and at 1,3,6 months after last PRP hair size

Countries

Thailand

Contacts

Public ContactCeline Valerie

Chulabhorn International College of Medicine, ThammasatUniversity

mintiizer@gmail.com026564500

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026